Skip to main navigation
Skip to search
Skip to main content
WashU Research Profiles Home
Help & FAQ
Link opens in a new tab
Search content at WashU Research Profiles
Home
Profiles
Research units
Research output
Indoleamine 2,3 dioxygenase in intestinal disease
Matthew A. Ciorba
Division of Gastroenterology
Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
Institute of Clinical and Translational Sciences (ICTS)
Siteman Cancer Center
Bursky Center for Human Immunology and Immunotherapy
Center of Regenerative Medicine
DBBS - Immunology
DBBS - Molecular Microbiology and Microbial Pathogenesis
DBBS - Cancer Biology
Research output
:
Contribution to journal
›
Review article
›
peer-review
113
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Indoleamine 2,3 dioxygenase in intestinal disease'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Intestinal Diseases
100%
Indoleamine 2,3-dioxygenase 1 (IDO1)
100%
Epithelium
27%
Gastrointestinal Diseases
27%
Inflammatory Bowel Disease
18%
Disease Biomarkers
18%
Clinical Trials
9%
Advanced Malignancies
9%
Disease Severity
9%
Malignancy
9%
Poor Prognosis
9%
Lamina Propria
9%
Recent Advances
9%
Inflammatory Response
9%
High-level Expression
9%
Colon Cancer
9%
Bioactive
9%
Antimicrobial Activity
9%
T-cell Mediated
9%
Disease Pathophysiology
9%
Kynurenine
9%
Indoleamine 2,3-dioxygenase 1 Inhibitor
9%
NewHope
9%
Tolerance Effect
9%
Malignancy-associated
9%
Intestinal Immune Homeostasis
9%
Tryptophan Catabolism
9%
Human Colon Cancer
9%
Refractory Crohn's Disease
9%
Kynurenine/tryptophan Ratio
9%
Medicine and Dentistry
Enteropathy
100%
Indoleamine 2,3 Dioxygenase
100%
Cancer
25%
Gastrointestinal Disease
25%
Epithelium
25%
Biological Marker
16%
Gut
16%
Tryptophan
16%
Kynurenine
16%
Colon Carcinoma
16%
Diseases
16%
Inflammatory Bowel Disease
16%
Serositis
8%
Clinical Trial
8%
Homeostasis
8%
Immunotherapy
8%
Pathophysiology
8%
T Cell
8%
Crohn's Disease
8%
Metabolite
8%
Hope
8%
Lamina Propria
8%
Catabolism
8%
Antimicrobial Agent
8%
Pharmacology, Toxicology and Pharmaceutical Science
Enteropathy
100%
Indoleamine 2,3 Dioxygenase
100%
Gastrointestinal Disease
25%
Biological Marker
16%
Colon Carcinoma
16%
Inflammatory Bowel Disease
16%
Tryptophan
16%
Kynurenine
16%
Diseases
16%
Clinical Trial
8%
Inflammation
8%
Pathophysiology
8%
Immunotherapy
8%
Crohn's Disease
8%
Antimicrobial Agent
8%
Immunology and Microbiology
Indoleamine 2,3-dioxygenase
100%
Epithelium
25%
Colon
16%
Inflammatory Bowel Disease
16%
Tryptophan
16%
Homeostasis
8%
T Cell
8%
Lamina Propria
8%
Immunotherapy
8%
Crohn's Disease
8%
Inflammation Response
8%
Experimental Model
8%
Metabolite
8%
Catabolism
8%
Antimicrobial Agent
8%
Biochemistry, Genetics and Molecular Biology
Indoleamine 2,3-dioxygenase
100%
Colon
16%
Tryptophan
16%
Kynurenine
16%
Grand Unified Theory
16%
T Cell
8%
Clinical Trial
8%
Homeostasis
8%
Metabolite
8%
Lamina Propria
8%
Hope
8%
Experimental Model
8%
Catabolism
8%